NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球性傳播疾病自我診斷市場:2021-2028

Global STD Self-Diagnostics Market - 2021-2028

出版商 DataM Intelligence 商品編碼 1024539
出版日期 內容資訊 英文 180 Pages
商品交期: 約2個工作天內
價格
全球性傳播疾病自我診斷市場:2021-2028 Global STD Self-Diagnostics Market - 2021-2028
出版日期: 2021年08月20日內容資訊: 英文 180 Pages
簡介

細菌或病毒感染會導致體內性傳播疾病 (STD)。 30多種傳染病通過精液、血液等體液的交換以及性病的直接接觸身體部位而傳播。性傳播疾病的自我診斷已成為救星,因為它不需要醫療保健專業人員,任何人都可以在幾分鐘內進行自我診斷。性傳播疾病自我診斷市場的增長正在增加全球各種性傳播疾病的發病率,增加久坐不動的生活方式,提高意識和患者教育,增加對快速準確診斷測試的需求,巴西,政府對性行為的激勵措施的存在印度和中國等發展中國家的傳播疾病檢測預計將支持市場增長。

本報告調查了全球性傳播疾病自我診斷市場,按類型、測試地點、測試設備、地區和進入市場的公司概況提供了市場概況、趨勢。

目錄

第 1 章世界性傳播疾病自我診斷調查方法及範圍

  • 調查方法
  • 調查的目的和範圍

第 2 章全球性傳播疾病自我診斷市場-市場定義和概述

第 3 章全球性傳播疾病自我診斷市場-執行摘要

  • 按類型劃分的市場細分
  • 按測試地點劃分的市場細分
  • 按測試設備劃分的市場細分
  • 按地區劃分的市場細分

第 4 章全球性傳播疾病自我診斷市場-市場動態

  • 影響市場的因素
    • 促進因素
    • 抑制因素
    • 市場機會
    • 影響分析

第 5 章全球性傳播疾病自我診斷市場-行業分析

  • 波特五力分析
  • PEST 分析
  • 供應鏈分析
  • 價格分析
  • 監管分析
  • 贖回分析
  • 未滿足的需求

第 6 章全球性傳播疾病自我診斷市場-COVID-19 分析

  • Covid-19 市場分析
    • 之前的 COVID-19 市場情景
    • COVID-19 當前市場情況
    • COVID-19 發佈或未來情景
  • Covid-19 中的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略計劃
  • 結論

第 7 章全球性傳播疾病自我診斷市場-按類型

  • 簡介
    • 按類型分列的市場規模分析和同比增長分析 (%)
    • 市場吸引力指數
  • 衣原體檢測
    • 簡介
    • 市場規模分析,100萬美元,2018-2028,以及同比增長分析(%),2020-2028
  • 梅毒檢測
  • 淋病檢測
  • 單純皰疹病毒檢測
  • 人乳頭瘤病毒檢測
  • 人類免疫缺陷病毒檢測
  • 軟下疳檢測
  • 其他

第 8 章全球性傳播疾病自我診斷市場-按檢測地點

  • 簡介
    • 市場規模分析,同比增長分析(%),按測試地點
    • 市場吸引力指數
  • 實驗室測試
    • 簡介
    • 市場規模分析,100萬美元,2018-2028,以及同比增長分析(%),2020-2028
    • 商業/私人實驗室
    • 公共衛生研究所
  • 護理點 (PoC) 檢查

第 9 章全球性傳播疾病自我診斷市場-按檢測設備

  • 簡介
    • 市場規模分析,同比增長分析(%),按檢測設備
    • 市場吸引力指數
  • 實驗設備
    • 簡介
    • 市場規模分析,100萬美元,2018-2028,以及同比增長分析(%),2020-2028
    • 熱循環儀-PCR
    • 橫向流動讀數器-免疫層析分析
    • 流式細胞儀
    • 差分光散射體
    • 吸光度□標儀-□聯免疫吸附測定 (ELISA)
    • 其他
  • 護理點 (PoC) 設備
    • 電話芯片(微流體 + ICT)
    • 便攜式/台式/快速診斷套件

第 10 章全球性傳播疾病自我診斷市場-按地區

  • 簡介
    • 2018-2028 年市場規模分析,100 萬美元,以及 2020-2028 年按地區分列的同比增長分析 (%)
    • 按地區劃分的市場吸引力指數
  • 北美
    • 簡介
    • 主要區域動態
    • 按類型分列的市場規模分析和同比增長分析 (%)
    • 市場規模分析,同比增長分析(%),按測試地點
    • 市場規模分析,同比增長分析(%),按測試設備
    • 按國家/地區劃分的市場規模分析和同比增長分析 (%)
  • 歐洲
    • 簡介
    • 主要區域動態
    • 按類型分列的市場規模分析和同比增長分析 (%)
    • 市場規模分析,同比增長分析(%),按測試地點
    • 市場規模分析,同比增長分析(%),按測試設備
    • 按國家/地區劃分的市場規模分析和同比增長分析 (%)
  • 南美洲
    • 簡介
    • 主要區域動態
    • 按類型分列的市場規模分析和同比增長分析 (%)
    • 市場規模分析,同比增長分析(%),按測試地點
    • 市場規模分析,同比增長分析(%),按測試設備
    • 按國家/地區劃分的市場規模分析和同比增長分析 (%)
  • 亞太地區
    • 簡介
    • 主要區域動態
    • 按類型分列的市場規模分析和同比增長分析 (%)
    • 市場規模分析,同比增長分析(%),按測試地點
    • 市場規模分析,同比增長分析(%),按測試設備
    • 按國家/地區劃分的市場規模分析和同比增長分析 (%)
  • 中東和非洲
    • 簡介
    • 主要區域動態
    • 按類型分列的市場規模分析和同比增長分析 (%)
    • 市場規模分析,同比增長分析(%),按測試地點
    • 市場規模分析,同比增長分析(%),按測試設備

第 11 章全球性傳播疾病自我診斷市場-競爭形勢

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準
  • 著名的大公司
  • 擁有顛覆性技術的公司
  • 創業公司

第 12 章全球性傳播疾病自我診斷市場-公司概況概述

  • F. Hoffmann-La Roche
    • 公司簡介
    • 產品組合和概述
    • 主要亮點
    • 財務概覽
  • Abbott Laboratories
  • Becton Dickinson and Company
  • Danaher Corporation
  • Affymetrix
  • BioMerieux
  • Cepheid Inc
  • Alere Inc
  • DiaSorin
  • Orasure

非詳盡列表

第 13 章全球性傳播疾病自我診斷市場-DataM

  • 附錄
  • 關於我們的公司和服務
  • 聯繫我們

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: DMMD3905

STD Self-Diagnostics Market Overview

The global STD self-diagnostics market size was valued US$ YY billion in 2019 and is estimated to reach US$ YY billion by 2028, growing at a CAGR of YY % during the forecast period (2021-2028).

A bacterial or viral infection causes Sexually Transmitted Disease (STD) in the body. More than 30 different infections are transmitted through the exchange of semen, blood, and other body fluids; or by direct contact with the affected body areas of people with STDs. STD self-diagnostics become a saviour because it does not require any medical professional, anyone can do self-testing in without any medical assistance within few minutes.

STD Self-Diagnostics Market Dynamics

The STD self-diagnostics market growth is driven by the increasing global incidence of various STIs, rise in sedentary lifestyle adoption levels, and rising awareness & patient education, increasing demand for rapid and accurate diagnostic tests and presence of favorable government initiatives for STD testing in developing countries such as Brazil, India, and China are further estimated to boost the market growth.

Increasing prevalence of sexually transmitted disease is expected to drive the growth in the forecast period

A bacterial or viral infection causes Sexually Transmitted Disease (STD) in the body. More than 30 different infections are transmitted through the exchange of semen, blood, and other body fluids; or by direct contact with the affected body areas of people with STDs. For instance, according to WHO 2019 report, more than 1 million Sexually Transmitted Infections (STIs) are acquired every day worldwide. Each year, there are an estimated 376 million new infections with 1 of 4 STIs.

Besides this, both developed and developing countries elevated their healthcare expenditure and spent on new technologies and Research and Development to increase the health quality of the population. According to WHO, US$ 8.3 trillion was spent on healthcare in 2020 globally. Therefore, all these factors can help grow STD self-diagnostics during the forecast period.

Growing government initiatives and national programs for sexually transmitted diseases is expected to drive the growth in the forecast period

Government initiatives and national programs for sexually transmitted diseases drive demand for the growth of the market. For Instances, In January 2020, Central Disease control continued to support specialty clinics by scaling up HIV prevention services in STD with the help of Notice of Funding Opportunity (NOFO).

STD self-diagnostics become a savior because it does not require any medical professional; anyone can do self-testing without any medical assistance within few minutes. It is rapid, easily available, and affordable. Therefore, all these factors drive the STD self-diagnostics sales during the forecast period.

Lack of awareness about STD self-diagnostics may hamper the market growth

Lack of awareness about STD self-diagnostics in developing countries and limited access to STD diagnosis in developing regions is expected to restrain the market growth.

COVID-19 Impact Analysis

Following the COVID-19 outbreak in December 2019, the disease has spread to over 100 countries globally, and the World Health Organization has declared it a public health emergency. According to the World Health Organization's report, the coronavirus (COVID-19) manifestation has resulted in more than 52.7 million infected individuals worldwide as of November 13, 2020.

COVID-19 has affected every market globally and has also impacted the global herpes simplex virus treatment market in the following ways; by directly affecting production and demand, creating disruptions in distribution channels, and its financial impact on firms and financial markets.

STD Self-Diagnostics Market Segment Analysis

The chlamydia testing segment is expected to hold largest share in this market segment

Chlamydia testing for sexually active women aged below 25 years is strictly recommended by the U.S Preventive Services Task Force (PSTF) owing to increasing prevalence of chlamydia infection globally. The prevalence of chlamydia was higher in women than in men. The prevalence for women varied from 1.1% to 10.6% and for men from 0.1% to 12.1%.

The laboratory testing devices segment is expected to hold largest share in this market segment

Laboratory testing devices segment dominated the market. Immunochromatographic assays were most preferred devices for STD diagnosis in laboratory testing devices segment. Increasing technological advancements are estimated to enhance usage rates of thermal cyclers over the forecast period. Factors such as faster diagnosis with POC tests and expected rise in adoption of POCs in future significantly contribute toward the growth of this segment.

The laboratory testing segment is expected to hold largest share in this market segment

Laboratory testing held the largest market share owing to the availability of cost-effective diagnostic tests used for multiple STIs at a single location such as public health labs.

STD Self-Diagnostics Market Geographical Analysis

North America region holds the largest market share of global STD self-diagnostics market

U.S. and Canada are the leading markets for STD self-diagnostics due to the region's high prevalence of the disease. According to Centres for Disease Control and Prevention (CDC) 2019 reported data, sexually transmitted is the most prevalent infectious disease 50-100 times higher than industrialized nations, about 85% in the U.S. One in four occurs in someone between the ages of 16 and 19.

About 12 million new STD infections occur in the United States each year. At the age of 25, more than 64% of people are affected by STD infections.

Also, the presence of key players, advancement and adoption of new technologies such as immunochromatographic device by Chembio Diagnostics Systems Inc played a vital role in increasing growth for the STD self-diagnostics in the region.

STD Self-Diagnostics Market Competitive Landscape

The global STD self-diagnostics market is moderately competitive with presence of global companies. Some of the key players which are contributing to the growth of the market include F. Hoffmann-La Roche, Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, Affymetrix, BioMerieux, Cepheid Inc., Alere Inc., DiaSorin, and Orasure. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, in march 2021, European Centre for Disease Prevention and Control initiated novel strategies and approaches (using existing and/or novel testing technologies) on access testing on key populations at-risk for sexually transmitted infections.

STD Self-Diagnostics Market Key Companies to Watch

F. Hoffmann-La Roche

Overview: F. Hoffman-La Roche AG is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives. F. Hoffman-La Roche AG is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognized as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).

Product Portfolio: The company is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system.

Key Developments: In May 2020, F. Hoffmann-La Roche Ltd has acquired Stratos Genomics. This enhances the diagnosis segment of the company.

Why Purchase the Report?

  • Visualize the composition of the STD self-diagnostics market segmentation by type, location of testing, testing device and region highlighting the key commercial assets and players.
  • Identify commercial opportunities in STD self-diagnostics market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of STD self-diagnostics market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global STD self-diagnostics market report would provide an access to an approx. 61 market data table, 55 figures and 180 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global STD Self-Diagnostics Market - By Type

  • Chlamydia testing
  • Syphilis testing
  • Gonorrhea testing
  • Herpes Simplex Virus testing
  • Human Papilloma Virus testing
  • Human Immunodeficiency Virus testing
  • Chancroid testing
  • Others

Global STD Self-Diagnostics Market - By Location of Testing

  • Laboratory Testing

Commercial/Private Labs

Public Health Labs

  • Point of Care (PoC) testing

Global STD Self-Diagnostics Market - By Testing Device

  • Laboratory Devices

Thermal Cyclers - PCR

Lateral Flow Readers - Immuno chromatographic assays

Flow Cytometers

Differential Light Scattering machines

Absorbance micro plate reader - Enzyme Linked Immunosorbent Assay (ELISA)

Others

  • Point of Care (PoC) Devices

Phone chips (micro fluidics + ICT)

Portable/bench top/rapid diagnostic kits

Global STD Self-Diagnostics Market - By Region

  • North America
  • Europe
  • Asia-Pacific
  • Middle East & Africa
  • South America

Table of Contents

1. Global STD Self-Diagnostics Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global STD Self-Diagnostics Market - Market Definition and Overview

3. Global STD Self-Diagnostics Market - Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Location of Testing
  • 3.3. Market Snippet by Testing Device
  • 3.4. Market Snippet by Region

4. Global STD Self-Diagnostics Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing prevalence of sexually transmitted disease
      • 4.1.1.2. Growing government initiatives and national programs for sexually transmitted diseases
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of awareness about STD self-diagnostics
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global STD Self-Diagnostics Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. PEST Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis
  • 5.6. Reimbursement Analysis
  • 5.7. Unmet Needs

6. Global STD Self-Diagnostics Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global STD Self-Diagnostics Market - By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Chlamydia testing*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Syphilis testing
  • 7.4. Gonorrhea testing
  • 7.5. Herpes Simplex Virus testing
  • 7.6. Human Papilloma Virus testing
  • 7.7. Human Immunodeficiency Virus testing
  • 7.8. Chancroid testing
  • 7.9. Others

8. Global STD Self-Diagnostics Market - By Location of Testing

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Location of Testing
    • 8.1.2. Market Attractiveness Index, By Location of Testing
  • 8.2. Laboratory Testing*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    • 8.2.3. Commercial/Private Labs
    • 8.2.4. Public Health Labs
  • 8.3. Point of Care (PoC) testing

9. Global STD Self-Diagnostics Market - By Testing Devices

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Testing Devices Segment
    • 9.1.2. Market Attractiveness Index, By Testing Devices Segment
  • 9.2. Laboratory Devices
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    • 9.2.3. Thermal Cyclers - PCR
    • 9.2.4. Lateral Flow Readers - Immuno chromatographic assays
    • 9.2.5. Flow Cytometers
    • 9.2.6. Differential Light Scattering machines
    • 9.2.7. Absorbance micro plate reader - Enzyme Linked Immunosorbent Assay (ELISA)
    • 9.2.8. Others
  • 9.3. Point of Care (PoC) Devices
    • 9.3.1. Phone chips (micro fluidics + ICT)
    • 9.3.2. Portable/bench top/rapid diagnostic kits

10. Global STD Self-Diagnostics Market - By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Location of Testing
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Testing Devices
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Location of Testing
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Testing Devices
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Location of Testing
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Testing Devices
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Location of Testing
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Testing Devices
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Location of Testing
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Testing Devices

11. Global STD Self-Diagnostics Market - Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. Key Companies to Watch
  • 11.5. Company with disruptive technology
  • 11.6. Start Up Companies

12. Global STD Self-Diagnostics Market- Company Profiles

  • 12.1. F. Hoffmann-La Roche*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Abbott Laboratories
  • 12.3. Becton Dickinson and Company
  • 12.4. Danaher Corporation
  • 12.5. Affymetrix
  • 12.6. BioMerieux
  • 12.7. Cepheid Inc
  • 12.8. Alere Inc
  • 12.9. DiaSorin
  • 12.10. Orasure

LIST NOT EXHAUSTIVE

13. Global STD Self-Diagnostics Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us